Sign in
4

Changes in Ownership

LENZ Therapeutics, Inc. Filed Acc 0000899243-21-027011

PRESIDENT AND CEO acquired 374,013 shares (option exercise)

  • PRESIDENT AND CEO acquired 8,126 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lehrer-Graiwer Joshua PRESIDENT AND CEO 2021-01-16 Option exercise +374,013 $0.30 $112,204 1,153,544 D
Lehrer-Graiwer Joshua PRESIDENT AND CEO 2021-06-29 Conversion +8,126 1,161,670 D
Derivatives
Lehrer-Graiwer Joshua PRESIDENT AND CEO 2021-01-13 Grant or award · Stock Option (right to buy) +374,013 374,013 D
Lehrer-Graiwer Joshua PRESIDENT AND CEO 2021-01-16 Option exercise · Stock Option (right to buy) −374,013 0 D
Lehrer-Graiwer Joshua PRESIDENT AND CEO 2021-03-11 Grant or award · Series B Preferred Stock +19,763 $5.06 $100,001 19,763 D
Lehrer-Graiwer Joshua PRESIDENT AND CEO 2021-03-17 Grant or award · Stock Option (right to buy) +795,196 795,196 D
Lehrer-Graiwer Joshua PRESIDENT AND CEO 2021-03-17 Grant or award · Stock Option (right to buy) +340,798 340,798 D
Lehrer-Graiwer Joshua PRESIDENT AND CEO 2021-06-29 Conversion · Series B Preferred Stock −19,763 0 D
Loading xslF345X03/doc4.xml…